Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
about
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsTigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-AnalysisStrategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of ChinaSystematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniaeA five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
P2860
Q26744583-3177B2E0-77A2-45A3-8091-FCD6A14CB996Q26764796-1487D15C-ACDB-48E8-AE7B-CBDE7D149820Q28082780-B8C2D110-EE4F-4C74-BE29-CEACAAB36709Q30235041-72A07A6E-1883-4A05-9663-487FB594F74BQ34535379-21B8F4FE-6134-4987-BCF8-4B13DF64550DQ35780609-FFFA054B-461C-4219-BD52-4B08DE1F9B3BQ35964808-3F64EB9F-4B76-4793-A3DC-25CE0318A76AQ39080538-13D0C22B-0C0D-4661-AC0A-6F53BFB831D2Q40530202-5BBA698D-3311-4B4D-AE7D-B3944B9BBFCEQ47313169-11648D56-AE8B-4648-92A7-A1ED2388E90CQ52695014-C7519183-FF89-4C5F-A4D6-633A6ED0F8EDQ55132888-E9AFB6DA-6875-4766-AB94-CF374F8305C2
P2860
Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Clinical features of patients ...... e multicenter study in Taiwan.
@en
type
label
Clinical features of patients ...... e multicenter study in Taiwan.
@en
prefLabel
Clinical features of patients ...... e multicenter study in Taiwan.
@en
P2093
P921
P1476
Clinical features of patients ...... e multicenter study in Taiwan.
@en
P2093
Chang-Phone Fung
Jann-Tay Wang
Jung-Chung Lin
L Kristopher Siu
Lih-Shinn Wang
Ling-Ju Huang
Po-Liang Lu
Tsu-Lan Wu
Yea-Yuan Chang
Yi-Tsung Lin
P304
P356
10.1016/J.JMII.2014.05.010
P577
2014-07-26T00:00:00Z